Abstract | BACKGROUND: STUDY DESIGN AND METHODS: The aim was to develop and validate HPA-1a NIPT by real-time polymerase chain reaction (PCR) or next-generation sequencing (NGS) for a high-throughput screening setting. DNA from 328 plasma samples of 299 HPA-1a negative pregnant women was examined for HPA-1a by real-time PCR and in two cases also by NGS (Ion Torrent). The results were compared with neonatal HPA-1a genotyping in 281 cases. RESULTS:
HPA-1a NIPT was negative in 44 of 51 HPA-1a negative fetuses, inconclusive in five, and false positive in two. In 228 of 229 HPA-1a positive fetuses, the NIPT results were positive (mean threshold cycle 36.0 ± 1.7) and inconclusive in one. In 22 cases with HPA-1a positive fetuses analyzed twice, the sensitivity of HPA-1a detection was significantly higher at 28 weeks compared with 16 to 20 weeks. NGS efficiently detected the ITGB3 coding HPA-1a/b (1% and 5% fetal HPA-1a reads). CONCLUSION: Real-time PCR is reliable to predict the fetal HPA-1a positive genotype in a screening study, but false-positive results are reported in 4%, with unnecessary prenatal treatment if anti-HPA-1a is detected.
|
Authors | Agnieszka Orzińska, Katarzyna Guz, Małgorzata Uhrynowska, Marzena Dębska, Michal Mikula, Jerzy Ostrowski, Maria Therese Ahlen, Anne Husebekk, Ewa Brojer |
Journal | Transfusion
(Transfusion)
Vol. 58
Issue 11
Pg. 2705-2711
(11 2018)
ISSN: 1537-2995 [Electronic] United States |
PMID | 30260485
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2018 AABB. |
Chemical References |
- Antigens, Human Platelet
- ITGB3 protein, human
- Integrin beta3
- Isoantibodies
|
Topics |
- Adult
- Antigens, Human Platelet
(genetics)
- Female
- Genotype
- Humans
- Infant, Newborn
- Integrin beta3
- Isoantibodies
(immunology)
- Pregnancy
- Prenatal Diagnosis
- Real-Time Polymerase Chain Reaction
- Thrombocytopenia, Neonatal Alloimmune
(genetics, immunology)
|